Development of a Non-Coding-RNA-based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Non-Coding-RNA-based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 1801885
Publisher
Wiley
Online
2019-03-07
DOI
10.1002/advs.201801885
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Redox and pH Dual-Responsive Polymeric Micelles with Aggregation-Induced Emission Feature for Cellular Imaging and Chemotherapy
- (2018) Weihua Zhuang et al. ACS Applied Materials & Interfaces
- MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2
- (2018) Lian Hui et al. BIOMEDICINE & PHARMACOTHERAPY
- Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer
- (2018) Hai Huang et al. CLINICAL CANCER RESEARCH
- Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma
- (2018) Hai-Rong Zhu et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
- (2018) Tian Fang et al. Nature Communications
- miRNA-125b-5p Suppresses Hypothyroidism Development by Targeting Signal Transducer and Activator of Transcription 3
- (2018) Liu Xiu et al. MEDICAL SCIENCE MONITOR
- miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522
- (2018) Yongzhen Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection
- (2017) Tomonari Shimagaki et al. HEPATOLOGY RESEARCH
- Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
- (2017) Joseph M. Luna et al. MOLECULAR CELL
- Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer
- (2017) Sisi Ma et al. Theranostics
- miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
- (2017) Dong Yang et al. Scientific Reports
- CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer
- (2017) Xinfeng Yu et al. Scientific Reports
- Poly(glycerol) Used for Constructing Mixed Polymeric Micelles as T1 MRI Contrast Agent for Tumor-Targeted Imaging
- (2016) Yi Cao et al. BIOMACROMOLECULES
- Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma
- (2016) Yu Guo et al. HEPATOLOGY
- Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
- (2016) Aparna Jayachandran et al. Journal of Hematology & Oncology
- Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche
- (2016) Olivier Govaere et al. JOURNAL OF HEPATOLOGY
- Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives
- (2016) José Eduardo Vargas et al. Journal of Translational Medicine
- Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics
- (2015) Ningning Yang et al. ADVANCED DRUG DELIVERY REVIEWS
- Role of microRNAs in maintaining cancer stem cells
- (2015) Michela Garofalo et al. ADVANCED DRUG DELIVERY REVIEWS
- MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4
- (2015) Jun-Nian Zhou et al. HEPATOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
- (2015) E Morelli et al. LEUKEMIA
- Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma
- (2015) K. S. Han et al. MOLECULAR CANCER THERAPEUTICS
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis
- (2014) Ruipeng Song et al. HEPATOLOGY
- STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function
- (2014) Salih Ibrahem et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma
- (2014) Burcu Gurer Giray et al. MOLECULAR BIOLOGY REPORTS
- Sources of Individual Variability: Mirnas That Predispose to Neuropathic Pain Identified Using Genome-Wide Sequencing
- (2014) Kiran Kumar Bali et al. Molecular Pain
- MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells
- (2014) Wei-Lun Hwang et al. NATURE CELL BIOLOGY
- Early Hepatocellular Carcinoma on the Procrustean Bed of Ablation, Resection, and Transplantation
- (2014) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Simultaneous Diagnosis and Gene Therapy of Immuno-Rejection in Rat Allogeneic Heart Transplantation Model Using a T-Cell-Targeted Theranostic Nanosystem
- (2012) Yu Guo et al. ACS Nano
- CaMKII , a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine
- (2012) Y. Gu et al. BLOOD
- Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b
- (2012) Jeong Kyu Kim et al. HEPATOLOGY
- 1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY
- (2012) J.M. Llovet et al. JOURNAL OF HEPATOLOGY
- Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGF
- (2012) Qian Bi et al. PLoS One
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
- (2011) Masatoshi Kudo et al. DIGESTIVE DISEASES
- Transoralgastric Gastroscopic Debridement for Peripancreatic Abscess: A Special Case Report
- (2011) Xing-Wei Wang et al. HEPATO-GASTROENTEROLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
- (2010) Masao Omata et al. Hepatology International
- A Short Hairpin DNA Analogous to miR-125b Inhibits C-Raf Expression, Proliferation, and Survival of Breast Cancer Cells
- (2009) M. H. Hofmann et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started